CAMH welcomes the decision today by the Supreme Court of Canada in the case of the Insite Supervised Injection Site in Vancouver, BC.
CAMH’s position has always been that the evidence about the health and social impacts of Insite should determine this issue, and the decision recognizes that the evidence supporting Insite is strong. We hope that research into the effectiveness of Insite as a public health initiative to reduce risk and harms will continue.
Media contact: Michael Torres, Media Relations, CAMH; 416-595-6015
The Centre for Addiction and Mental Health (CAMH) is Canada’s largest mental health and addiction teaching hospital, as well as one of the world’s leading research centres in the area of addiction and mental health. CAMH combines clinical care, research, education, policy development, prevention and health promotion to transform the lives of people affected by mental health and addiction issues.
CAMH is fully affiliated with the University of Toronto, and is a Pan American Health Organization/World Health Organization Collaborating Centre.